Abstract
Hematologic abnormalities are reported in Coronavirus disease (COVID-19) infection, all blood cells can be affected, mainly leukocyte and platelet cells. blood smears are not systematically requested, but given the quantitative abnormalities, a qualitative evaluation is therefore useful to analyze cytological changes during COVID-19.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
